Lipella Pharmaceuticals Financials
| LIPO Stock | 2.95 0.15 5.36% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.34 | 8.899 |
|
|
The financial analysis of Lipella Pharmaceuticals is a critical element in measuring its lifeblood. Investors should not minimize Lipella Pharmaceuticals' ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
Lipella | Select Account or Indicator |
Understanding current and past Lipella Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Lipella Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in Lipella Pharmaceuticals' assets may result in an increase in income on the income statement.
Lipella Pharmaceuticals Stock Summary
Lipella Pharmaceuticals competes with Senti Biosciences, Fennec Pharmaceuticals, Monopar Therapeutics, Ascletis Pharma, and Transgene. Lipella Pharmaceuticals is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 53630L100 |
| Location | Pennsylvania; U.S.A |
| Business Address | 7800 Susquehanna St, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.lipella.com |
| Phone | 412 901 0315 |
Lipella Pharmaceuticals Key Financial Ratios
| Return On Equity | -1.72 | ||||
| Operating Margin | (6.98) % | ||||
| Price To Sales | 7.03 X | ||||
| Revenue | 449.62 K | ||||
| Gross Profit | (2.36 M) |
Lipella Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Lipella Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Lipella Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lipella Pharmaceuticals competition to find correlations between indicators driving Lipella Pharmaceuticals's intrinsic value. More Info.Lipella Pharmaceuticals Common is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Lipella Pharmaceuticals' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lipella Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Lipella Pharmaceuticals Systematic Risk
Lipella Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Lipella Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Lipella Pharmaceuticals correlated with the market. If Beta is less than 0 Lipella Pharmaceuticals generally moves in the opposite direction as compared to the market. If Lipella Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Lipella Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Lipella Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Lipella Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Lipella Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Lipella Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Lipella Pharmaceuticals growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Lipella Pharmaceuticals November 29, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Lipella Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Lipella Pharmaceuticals Common. We use our internally-developed statistical techniques to arrive at the intrinsic value of Lipella Pharmaceuticals Common based on widely used predictive technical indicators. In general, we focus on analyzing Lipella Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Lipella Pharmaceuticals's daily price indicators and compare them against related drivers.
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 48.01 | |||
| Value At Risk | (8.43) | |||
| Potential Upside | 12.47 |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lipella Pharmaceuticals Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipella Pharmaceuticals. If investors know Lipella will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipella Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.88) | Revenue Per Share 0.592 | Quarterly Revenue Growth 0.279 | Return On Assets (0.94) | Return On Equity (1.72) |
The market value of Lipella Pharmaceuticals is measured differently than its book value, which is the value of Lipella that is recorded on the company's balance sheet. Investors also form their own opinion of Lipella Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Lipella Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipella Pharmaceuticals' market value can be influenced by many factors that don't directly affect Lipella Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipella Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipella Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipella Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.